Answers are grounded in this paper and cite their sources.
: The renewed reliance experienced during the pandemic and the unprecedented injection of resources through recovery instruments can further boost the development of apps. Only robust evidence of the benefits of mHealth apps will persuade health-care professionals and beneficiaries to systematically deploy them. Regulatory bodies will need to question their current approaches by adopting comprehensive evaluation processes that adequately consider the specific features of mHealth apps.
No takes yet. Share an insight, caveat, or question.
Tarricone et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: